Magnetic resonance spectroscopy in intracranial infection

Clinical MR Neuroimaging: Physiological and Functional Techniques, Second Edition

Volumn , Issue , 2011, Pages 426-449

  Gupta, Rakesh K ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DIAGNOSIS; MAGNETIC RESONANCE SPECTROSCOPY; MAGNETISM; MICROORGANISMS; NONINVASIVE MEDICAL PROCEDURES; RESONANCE;

CENTRAL NERVOUS SYSTEMS; DIAGNOSTIC TECHNIQUES; MAGNETIC RESONANCE IMAGING (MRI); MAGNETIC RESONANCE SPECTROSCOPIES (MRS); METABOLIC INFORMATION; NON-INVASIVE DIAGNOSTICS; NON-INVASIVE IMAGING; PATHOGENIC MICROORGANISMS;

MAGNETIC RESONANCE IMAGING;

EID: 85011411915     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9781139193481.031     Document Type: Chapter

References (108)

1. Evans AS. Epidemiological concepts. In Bacterial Infections of Humans, eds. Evans AS, Brachman PS. New York: Plenum, 1990, pp. 3-57.
2. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults. New Engl J Med 1993; 328: 21-28.
3. Zimmerman RA, Bilaniuk LT, Sze G. Intracranial infection. In Magnetic Resonance Imaging of the Central Nervous System, eds. Brant-Zawadzki M, Norman D. New York: Raven Press, 1987, pp. 235-257.
4. Runge VM, Welle JW, Williams NM, et al. Detectability of early brain meningitis with magnetic resonance imaging. Invest Radiol 1995; 30: 484-495.
5. Tsuchiya K, Inaoka S, Mizutani Y, Hachiya J. Fast fluid-attenuated inversionrecovery MR of intracranial infections. AJNR Am J Neuroradiol 1997; 18: 909-913.
6. Matthews PM, Shoubridge E, Arnold DL. Brain phosphorus magnetic resonance spectroscopy in acute bacterial meningitis. Arch Neurol 1989; 46: 994-996.
7. Shawl S. Neurologic evaluation of patient with acute bacterial meningitis. Neurol Clin 1995; 13: 549-577.
8. Venkatesh SK, Gupta RK. Pyogenic infections. In MR Imaging and Spectroscopy of Central Nervous System Infection, eds. Gupta RK, Lufkin RB. New York: Kluwer Academic/Plenum, 2001, pp. 57-93.
9. Trivedi R, Malik GK, Gupta RK, et al. Increased anisotropy in neonatal meningitis: an indicator of meningeal inflammation. Neuroradiology 2007; 49: 767-775.
10. Nath K, Husain M, Trivedi R, et al. Clinical implications of increased fractional anisotropy in meningitis associated with brain abscess. J Comput Assist Tomogr 2007; 31: 888-893.
11. Yadav A, Malik GK, Trivedi R, et al. Correlation of CSF neuroinflammatory molecules with leptomeningeal cortical subcortical white matter fractional anisotropy in neonatal meningitis. Magn Reson Imaging 2008; 27: 214-221.
12. Malik GK, Trivedi R, Gupta A, et al. Quantitative DTI assessment of periventricular white matter changes in neonatal meningitis. Brain Dev 2008; 30: 334-341.
13. Habib AA, Mozaffar T. Brain abscess. Arch Neurol 2001; 58: 1302-1304.
14. Osenbach RK, Loftus CM. Diagnosis and management of brain abscess. Neurosurg Clin N Am 1992; 3: 403-420.
15. Britt RH, Enzmann DR, Yeager AS. Neuropathological and computerized tomographic findings in experimental brain abscess. J Neurosurg 1981; 55: 590-603.
16. Kim SH, Chang KH, Song IC, et al. Brain abscess and brain tumor: discrimination with in vivo H-1 MR spectroscopy. Radiology 1997; 204: 239-245.
17. Gupta RK, Vatsal DK, Husain N, et al. Differentiation of tuberculous from pyogenic brain abscesses with in vivo proton MR spectroscopy and magnetization transfer MR imaging. AJNR Am J Neuroradiol 2001; 22: 1503-1509.
18. Sudhakar KV, Agarwal S, Rashid MR, et al. MRI demonstration of haemorrhage in the wall of a brain abscess: possible implications for diagnosis and management. Neuroradiology 2001; 43: 218-222.
19. Holtas S, Geijer B, Stromblad LG, Maly-Sundgren P, Burtscher IM. A ringenhancing metastasis with cerebral high signal on diffusion-weighted imaging and low apparent diffusion coefficients. Neuroradiology 2000; 42: 824-827.
20. Ebisu T, Tanaka C, Umeda M, et al. Discrimination of brain abscess from necrotic or cystic tumors by diffusion-weighted echo planar imaging. Magn Reson Imaging 1996; 14: 1113-1116.
21. Mikami T, Saito K, Kato T, Detection and characterization of the evaluation of cerebral abscesses with diffusionweighted magnetic resonance imaging: two case reports. Neurol Med Chir 2002; 42: 86-90.
22. Shukla-Dave A, Gupta RK, Roy R, et al. Prospective evaluation of in vivo proton MR spectroscopy in differentiation of similar appearing intracranial cystic lesions. Magn Reson Imaging 2001; 19: 103-110.
23. Gupta RK. Tuberculosis and other non-tuberculous bacterial graunulomatous infections. In MR Imaging and Spectroscopy of Central Nervous System Infection, eds. Gupta RK, Lufkin RB. New York: Kluwer Academic/Plenum, 2001, pp. 95-145.
24. Garg M, Gupta RK, Husain M, et al. Etiological categorization of brain abscesses with in vivo proton MR spectroscopy. Radiology 2004; 230: 893-899.
25. Lai PH, Ho JT, Chen WL, Brain abscess and necrotic brain tumor: discrimination with proton MR spectroscopy and diffusionweighted imaging. AJNR Am J Neuroradiol 2002; 23: 1369-1377.
26. Lai PH, Hsu SS, Ding SW, et al. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions. Surg Neurol 2007; 68 (Suppl 1): S25-S36..
27. Mishra AM, Gupta RK, Jaggi RS, et al. Role of diffusionweighted imaging and in vivo proton magnetic resonance spectroscopy in the differential diagnosis of ringenhancing intracranial cystic mass lesions. J Comput Assist Tomogr 2004; 28: 540-547.
28. Mishra AM, Gupta RK, Saksena S, et al. Biological correlates of diffusivity in brain abscess. Magn Reson Med 2005; 54: 878-885.
29. Gupta RK, Hasan KM, Mishra AM, et al. High fractional anisotropy in brain abscesses versus other cystic intracranial lesions. AJNR Am J Neuroradiol 2005; 26: 1107-1114.
30. Gupta RK, Nath K, Prasad A, et al. In vivo demonstration of neuroinflammatory molecule expression in brain abscess with diffusion tensor imaging. AJNR Am J Neuroradiol 2008; 29: 326-332.
31. Nath K, Agarwal M, Ramolla M, et al. Role of diffusion tensor imaging metrics and in vivo proton MR spectroscopy in the differential diagnosis of cystic intracranial mass lesions. Magn Reson Imaging 2009; 27: 198-206.
32. Tandon PN, Pathak SN. Tuberculosis of the central nervous system. In Tropical Neurology, ed. Spillane JD. New York: Oxford University Press, 1973, pp. 37-62.
33. Hopewell PC. Overview of clinical tuberculosis. In Tuberculosis: Pathogenesis, Protection, and Control, ed. Bloom BR. Washington, DC: American Society of Microbiology, 1994, pp. 25-46.
34. Gupta R. Magnetization transfer MR imaging in central nervous system infections. Ind J Radiol Imaging 2002; 12: 51-58.
35. Gupta RK, Kathuria MK, Pradhan S. Magnetization transfer MR imaging in CNS tuberculosis. AJNR Am J Neuroradiol 1999; 20: 867-875.
36. Kamra P, Azad R, Prasad KN, et al. Infectious meningitis: prospective evaluation with magnetization transfer MRI. Br J Radiol 2004; 77: 387-394.
37. Gupta RK, Pandey R, Khan EM, et al. Intracranial tuberculomas: MRI signal intensity correlation with histopathology and localized proton spectroscopy. Magn Reson Imaging 1993; 11: 443-449.
38. Gupta RK, Husain N, Kathuria MK, et al. Magnetization transfer MR imaging correlation with histopathology in intracranial tuberculomas. Clin Radiol 2001; 56: 656-663.
39. Saxena S, Prakash M, Kumar S, Gupta RK. Comparative evaluation of magnetization transfer contrast and fluid attenuated inversion recovery sequences in brain tuberculoma. Clin Radiol 2005; 60: 787-793.
40. Gupta RK, Roy R, Dev R, et al. Finger printing of Mycobacterium tuberculosis in patients with intracranial tuberculomas by using in vivo, ex vivo, and in vitro magnetic resonance spectroscopy. Magn Reson Med 1996; 36: 829-833.
41. Jackson A. Imaging microvascular structure with contrast enhanced MRI. Br J Radiol 2003; 76: S159-S173.
42. Padhani AR, Husband JE. Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clin Radiol 2001; 56: 607-620.
43. Gupta RK, Haris M, Husain N, et al. Relative cerebral blood volume is a measure of angiogenesis in brain tuberculoma. J Comput Assist Tomogr 2007; 31: 335-341.
44. Haris M, Gupta RK, Husain M, et al. Assessment of therapeutic response on serial dynamic contrast enhanced MR imaging in brain tuberculomas. Clinical Radiology 2008; 63: 562-574.
45. Hrabec E, Strek M, Zieba M, Kwiatkowska S, Hrabec Z. Circulation level of matrix metalloproteinase-9 is correlated with disease severity in tuberculosis patients. Int J Tuberc Lung Dis 2002; 6: 713-719.
46. Leib SL, Leppert D, Clements J, Täuber MG. Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect Immun 2000; 68: 615-620.
47. Matsuura E, Umehara F, Hashiguchi T, et al. Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis. J Neurol Sci 2000; 173: 45-52.
48. Whitener DR. Tuberculous brain abscess. Arch Neurol 1978; 35: 148-155.
49. Farrar DJ, Flanigan TP, Gordon NM, Gold RL, Rich JD. Tuberculous brain abscess in a patient with HIV infection: case report and review. Am J Med 1997; 102: 297-301.
50. Luthra G, Parihar A, Nath K, et al. Comparative evaluation of fungal, tubercular, and pyogenic brain abscesses with conventional and diffusion MR imaging and proton MR spectroscopy. AJNR Am J Neuroradiol 2007; 28: 1332-1338.
51. Reddy JS, Mishra AM, Behari S, et al. Role of diffusion-weighted imaging in the differential diagnosis of intracranial cystic mass lesions: a report of 147 lesions. Surg Neurol 2006; 66: 246-250.
52. Gupta RK, Prakash M, Mishra AM, et al. Role of diffusion weighted imaging in differentiation of intracranial tuberculoma and tuberculous abscess from cysticercus granulomas: a report of more than 100 lesions. Eur J Radiol 2005; 55: 384-392.
53. Tien RD, Felsberg GJ, Osumi AK. Herpesvirus infections of the CNS: MR findings. Am J Roentgenol 1993; 161: 167-176.
54. Lakeman FD, Whitley RJ. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. J Infect Dis 1995; 171: 857-863.
55. Morawetz RB, Whitley RJ, Murphy DM. Experience with brain biopsy for suspected herpes encephalitis: review of forty consecutive cases. Neurosurgery 1983; 12: 654-657.
56. Gupta RK, Lufkin RB. Viral infections. In MR Imaging and Spectroscopy of Central Nervous System infection, eds. Gupta RK, Lufkin RB. New York: Kluwer Academic/Plenum, 2001, pp. 147-175.
57. Tsuchiya K, Katase S, Yoshino A, Hachiya J. Diffusion-weighted MR imaging of encephalitis. Am J Roentgenol 1999; 173: 1097-1099.
58. Sener RN. Herpes simplex encephalitis: diffusion MR imaging findings. Comput Med Imaging Graph 2001; 25: 391-397.
59. Heiner L, Demaerel P. Diffusion-weighted MR imaging findings in a patient with herpes simplex encephalitis. Eur J Radiol 2003; 45: 195-198.
60. Duckworth JL, Hawley JS, Riedy G, Landau ME. Magnetic resonance restricted diffusion resolution correlates with clinical improvement and response to treatment in herpes simplex encephalitis. Neurocrit Care 2005; 3: 251-253.
61. Samann PG, Schlegel J, Muller G, et al. Serial proton MR spectroscopy and diffusion imaging findings in HIV-related herpes simplex encephalitis. AJNR Am J Neuroradiol 2003; 24: 2015-2019.
62. Menon DK, Sargentoni J, Peden CJ, et al. Proton MR spectroscopy in herpes simplex encephalitis: assessment of neuronal loss. J Comput Assist Tomogr 1990; 14: 449-452.
63. Demaerel P, Wilms G, Robberecht W, et al. MRI and herpes simplex encephalitis. Neuroradiology 1992; 32: 490-493.
64. Takanashi J, Sugita K, Ishii M, Aoyagi M, Niimi H. Longitudinal MR imaging and proton MR spectroscopy in herpes simplex encephalitis. J Neurol Sci 1997; 149: 99-102.
65. Herweh C, Jayachandra MR, Hartmann M, et al. Quantitative diffusion tensor imaging in herpes simplex virus encephalitis. J Neurovirol 2007; 13: 426-432.
66. Silverstein A, Steinberg G, Nathanson M. Nervous system involvement in infectious mononucleosis: the heralding and-or major manifestation. Arch Neurol 1972; 26: 353-358.
67. Ross JP, Cohen JI. Epstein-Barr virus. In Infections of the Central Nervous System, eds. Scheld WM, Whitley RJ, Durack DT. Philadelphia, PA: Lippincott-Raven Press, 1997; pp. 117-127.
68. Cecil KM, Jones BV, Williams S, Hedlund GL. CT, MRI and MRS of Epstein-Barr virus infection: case report. Neuroradiology 2000; 42: 619-622.
69. Hagemann G, Mentzel HJ, Weisser H, Kunze A, Terborg C. Multiple reversible MR signal changes caused by Epstein-Barr virus encephalitis. AJNR Am J Neuroradiol 2006; 27: 1447-1449.
70. Parameshwaran K, Radhakrishnan K. Subacute sclerosing panencephalitis. In Reviews in Tropical Neurology, eds. Kar AM, Shukla R, Agarwal A, Verma R. Lucknow: Shivam Arts, 2002, pp. 30-40.
71. Sener RN. Subacute sclerosing panencephalitis findings at MR imaging, diffusion MR imaging, and proton MR spectroscopy. AJNR Am J Neuroradiol 2004; 25: 892-894.
72. Salvan AM, Confort-Gouny S, Cozzone PJ, et al. In vivo cerebral proton MRS in a case of subacute sclerosing panencephalitis. J Neurol Neurosurg Psychiatr 1999; 66: 547-555.
73. 1H-MRS. Neurology 2006; 67: 911-913.
74. Trivedi R, Gupta RK, Agarawal A, et al. Assessment of white matter damage in subacute sclerosing panencephalitis using quantitative diffusion tensor MR imaging. AJNR Am J Neuroradiol 2006; 27: 1712-1716.
75. Ishii K. Virological and serological diagnosis of Japanese encephalitis. Shinkei Kenkyu No Shimpo 1967; 11: 300-311.
76. Kumar S, Misra UK, Kalita J, MRI in Japanese encephalitis. Neuroradiology 1997; 39: 180-184.
77. Harada M, Hisaoka S, Mori K, et al. Difference in water diffusion and lactate production in two different types of postinfectious encephalopathy. J Magn Reson Imaging 2000; 11: 559-563.
78. Caldemeyer KS, Smith RR, Harris TM, Edwards MK. MRI in acute disseminated encephalomyelitis. Neuroradiology 1994; 36: 216-220.
79. Balasubramanya KS, Kovoor JME, Jayakumar PN, et al. Diffusion-weighted imaging and proton MR spectroscopy in the characterization of acute disseminated encephalomyelitis. Neuroradiology 2007; 49: 177-183.
80. Goo HW, Choi CG, Yoon CH, Ko TS. Acute necrotizing encephalopathy: Diffusion MR imaging and localized proton MR spectroscopic findings in two infants. Korean J Radiol 2003; 4: 61-65.
81. Satishchandra P, Sharma GRK. Fungal infections of the nervous system. In Reviews in Tropical Neurology, eds. Garg RK, Kar AM, Agarwal A, Shukla R, Verma R. Lucknow: Shivam Arts, 2002, pp. 111-124.
82. Sepkowitz K, Armstrong D. Space-occupying fungal lesions. In Infections of the Central Nervous System, eds. Scheld WM, Whitley RJ, Durack DT. Philadelphia, PA: Lippincott-Raven Press, 1997, pp. 741-762.
83. Meyer RD, Young LS, Armstrong D, Yu B. Aspergillosis complicating neoplastic disease. Am J Med 1973; 54: 6-15.
84. Kathuria MK, Gupta RK. Fungal infections. In MR Imaging and Spectroscopy of Central Nervous System Infection, eds. Gupta RK, Lufkin RB. New York: Kluwer Academic/Plenum, 2001; pp. 177-203.
85. Himmelreich U, Dzendrowoskyj TE, Allen C, et al. Cryptococcomas distinguished from gliomas with MR spectroscopy: an experimental rat and cell culture study. Radiology 2001; 220: 122-128.
86. Dzendrowskyi T, Himmelreich U, Malik R, et al. Distinction between cerebral cryptococcomas, Staphylococcus aureus infections and tumours in an animal model. In Proceedings of the Eighth Annual Meeting of the International Society for Magnetic Resonance in Medicine, Denver, 2000, p. 173.
87. Siegal JA, Cacayorin ED, Nassif AS, et al. Cerebral mucormycosis: proton MR spectroscopy and MR imaging. Magn Reson Imaging 2000; 18: 915-920.
88. Garg RK, Kar AM. Neurocysticercosis: diagnosis and treatment in special situations. In Taenia solium Cysticercosis from Basic to Clinical Science, eds. Singh G, Prabhakar S. New York: CAB International, 2002, pp. 281-287.
89. Carpio A, Hauser WA. Neurocysticercosis and epilepsy. In Taenia solium Cysticercosis from Basic to Clinical Science, eds. Singh G, Prabhakar S. New York: CAB International, 2002, pp. 211-220.
90. Garcia HH, Gilman RH, Catacora M, et al. Serologic evolution of neurocysticercosis patients after antiparasitic therapy. Cysticercosis Working Group in Peru. J Infect Dis 1997; 175: 486-489.
91. Wilkins PP, Wilson M, Allan JC, Tsang VCW. Taenia solium cysticercosis: immunodiagnosis of neurocysticercosis and taeniasis. In Taenia solium Cysticercosis from Basic to Clinical Science, eds. Singh G, Prabhakar S. New York: CAB International, 2002, pp. 329-341.
92. Gupta RK, Chang KH. Parasitic infections. In MR Imaging and Spectroscopy of Central Nervous System Infection, eds. Gupta RK, Lufkin RB. New York: Kluwer Academic/Plenum, 2001; pp. 205-239.
93. Sharma K, Gupta RK. Scannegative neurocysticercosis. Pediatr Neurosurg 1993; 19: 206-208.
94. Sharda D, Chawla S, Gupta RK. Imaging and spectroscopy of neurocysticercosis. In Taenia solium Cysticercosis from Basic to Clinical Science, eds. Singh G, Prabhakar S. New York: CAB International, 2002; pp. 311-327.
95. Chawla S, Gupta RK, Kumar R, et al. Demonstration of scolex in calcified cysticercus lesion using gradient echo with or without corrected phase imaging and its clinical implications. Clin Radiol 2002; 57: 826-834.
96. Kathuria MK, Gupta RK, Roy R, et al. Measurement of magnetization transfer in different stages of neurocysticercosis. J Magn Reson Imaging 1998; 8: 473-479.
97. Pandit S, Lin A, Gahbauer H, Libertin CR, Erdogan B. MR spectroscopy in neurocysticercosis. J Comput Assist Tomogr 2001; 25: 950-952.
98. Chawla S, Gupta RK, Husain N, et al. Prediction of viability of neurocysticercosis with proton magnetic resonance spectroscopy and its correlation with histopathology. Life Sci 2004; 74: 1081-1092.
99. Garg M, Chawla S, Prasad KN, et al. Differentiation of hydatid cyst from cysticercus cyst by proton MR spectroscopy. NMR Biomed 2002; 15: 320-326.
100. Rudman MA, Khaffai S. CT of cerebral hydatid disease. Neuroradiology 1988; 30: 496-499.
101. Önal Ç, Barlas O, Orakdögen M, et al. Three unusual cases of intracranial hydatid cyst in the pediatric age group. Pediatr Neurosurg 1997; 26: 208-213.
102. Nurchi G, Floris F, Montaldo C, et al. Multiple cerebral hydatid disease: case report with magnetic resonance imaging study. Neurosurgery 1992; 30: 436-438.
103. Kohli A, Gupta RK, Poptani H, Roy R. In vivo proton magnetic resonance spectroscopy in a case of intracranial hydatid cyst. Neurology 1995; 45: 562-564.
104. Novak M, Hameed N, Buist R, Blackburn BJ. Metabolites of alveolar Echinococcus as determined by 31-P and 1 H nuclear magnetic resonance spectroscopy. Parasitol Res 1992; 78: 665-670.
105. Garg M, Gupta RK, Prasad KN, et al. Fertility assessment of hydatid cyst by proton MR spectroscopy. J Surg Res 2002; 106: 196-201.
106. Kingsley PB, Shah TC, Woldenberg R. Identification of diffuse and focal brain lesions by clinical magnetic resonance spectroscopy. NMR Biomed 2006; 19: 435-462.
107. Marsden PD, Bruce-Chwatt IJ. Cerebral malaria. In Topics on Tropical Neurology, ed. Hornabrook RW. Philadelphia, PA: Devis, 1975; pp. 29-44.
108. Sanni LA, Rae C, Maitiland A, Stocker R, Hunt NH. Is ischemia involved in the pathogenesis of murine cerebral malaria? Am J Pathol 2001; 159: 1105-1112.